PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro</i> and <i>In Vivo</i>Lisa Marie Fröhlich, Birgit Schittek|Cancer Research Communications|2023Cited by 15
<scp>PARP1</scp> expression predicts <scp>PARP</scp> inhibitor sensitivity and correlates with metastatic potential and overall survival in melanomaLisa Marie Fröhlich, Birgit Schittek|International Journal of Cancer|2024Cited by 12